Results 31 to 40 of about 90,516 (299)
Clinical Immunology Communications, 2023 We analyzed immune response to SARS-CoV-2 vaccination by measuring specific IgG titers and T-cell reactivity to different SARS-CoV-2 peptides in multiple sclerosis patients taking different disease-modifying treatments.
Virginia Meca-Lallana +12 more
doaj +1 more source
ADEM as an Initial Presentation of SLE: A Case Report
ReportsAcute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disorder of the white matter. The pathophysiology is thought to be immune-mediated as in most cases the condition follows an infection or triggering incident.
Yousuf Sherwani +2 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2019 We report a rare case of acute disseminated encephalomyelitis (ADEM) secondary to a primary Epstein-Barr (EBV) infection, in a 22-year-old male. Symptomatic infectious mononucleosis and ADEM are both quite uncommon conditions in this age group.
Deeba Ali +8 more
doaj +1 more source
NEW METHODS OF DIAGNOSIS DIABETIC NEUROPATHY
Бюллетень сибирской медицины, 2013 Diabetic neuropathy is the most common complications of diabetes and is a leading cause of disability of patients. According to epidemiological studies, depending on the methods of examination frequency of diabetic neuropathy among the patients ranged ...
R. B. Tsyrenzhapova, V. M. Alifirova
doaj +1 more source
Tracking the impact of multiple sclerosis on employment status: the development of a questionnaire
Arquivos de Neuro-Psiquiatria, 2022 Background Multiple sclerosis (MS) has a negative effect on employment status.
Evangelina Valeria Cores +6 more
doaj +1 more source
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks [PDF]
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a treatable autoimmune disorder, for which different treatment options are available.
Rajabally, Yusuf A.
core +2 more sources
Features of multiple sclerosis in childhood in the Republic of Tatarstan
Неврология, нейропсихиатрия, психосоматика, 2023 Multiple sclerosis (MS) in children and adolescents is a genuine concern of pediatric neurology that specialists in all countries are dealing with. To date, neither the causes of onset nor the individual components of the pathogenesis of the disease have
A. R. Khaibullina +2 more
doaj +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Annals of Clinical and Translational Neurology, EarlyView.Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Frontiers in Immunology, 2023 Current understanding of Multiple Sclerosis (MS) pathophysiology implicates perturbations in adaptive cellular immune responses, predominantly T cells, in Relapsing-Remitting forms (RRMS).
Aigli G. Vakrakou +13 more
doaj +1 more source
Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan +14 more
wiley +1 more source